American College of Medical Toxicology

Opioid and Stimulant Overdose Reporting Program to Expand Under Increased Federal Funding

Retrieved on: 
Tuesday, October 17, 2023
COVID-19, Drug Safety, American College of Medical Toxicology, Research, Toxicity, American College, Medicine, Drug overdose, Plasma protein binding, Patient, FDA, Abuse, DOTS, Maintenance, Drug, DO, Physician, Pharmaceutical industry, Education

This project was expanded with a contract award in September 2023, titled the Drug Overdose Toxico-Surveillance (DOTS) Reporting Program , which was created with the aim to provide accurate data on the evolving role of polysubstance use in non-fatal opioid- and stimulant-involved drug overdoses.

Key Points: 
  • This project was expanded with a contract award in September 2023, titled the Drug Overdose Toxico-Surveillance (DOTS) Reporting Program , which was created with the aim to provide accurate data on the evolving role of polysubstance use in non-fatal opioid- and stimulant-involved drug overdoses.
  • Comprehensive laboratory testing of the samples is conducted by the Center for Forensic Science Research and Education (CFSRE) .
  • CSFRE testing methods facilitate detection of over one thousand analytes (prescription drugs and illicit substances, including novel emerging substances).
  • Led by medical toxicology physicians and registry experts, our projects involve case registry design and maintenance.

Fentanyl, Xylazine, Cannabinoids to Feature in Virtual Forensic Toxicology Seminar December 14 - 15, 2023

Retrieved on: 
Monday, October 16, 2023
NMS, Physician, Highway patrol, Lab, Doctor of Philosophy, Drug Safety, American College of Medical Toxicology, Maastricht University, American College, Medicine, Q & A, Road, Continuing medical education, CME, Xylazine, Benzodiazepine, Fentanyl, Science and technology in Asia, Emergency, Cannabis, Harm reduction, Law enforcement, FSB Criminalistics Institute, Worlds, Legal nurse consultant, State, Research, The central science, NPS, Management, Nursing, Education, Cannabinoid, Psychopharmacology

The program opens with “Cannabis and the Expanding World of Cannabinoids” on Thursday, December 14th.

Key Points: 
  • The program opens with “Cannabis and the Expanding World of Cannabinoids” on Thursday, December 14th.
  • Topics covered include the legalization of cannabis, challenges with prosecuting marijuana DUIs, and the rise in use and adverse events with cannabinoid products.
  • The seminar will also explore the landscape of new psychoactive substances (NPS), drug delivery homicide cases, and advancements in clinical toxicology testing.
  • The American College of Medical Toxicology (ACMT) is a professional, nonprofit association of physicians with recognized expertise and board certification in medical toxicology.

Out-of-Hospital Naloxone Administration to be Studied in New Federally-Funded Project

Retrieved on: 
Monday, October 2, 2023
Maintenance, Medicine, Drug Safety, BAA, Research, EMS, Abuse, MD, Patient, Physician, Emergency medical services, Toxicity, American College of Medical Toxicology, American College, FDA, Pharmaceutical industry, Nursing, Naloxone

This 4-year (base and 3 option years) project, titled “ Real-World Examination of Naloxone for Drug Overdose Reversal (RENDOR) ,” will study out-of-hospital naloxone administration through a collaboration with EMS agencies in San Francisco, CA; Detroit, MI; Portland, OR; and Pittsburgh, PA.

Key Points: 
  • This 4-year (base and 3 option years) project, titled “ Real-World Examination of Naloxone for Drug Overdose Reversal (RENDOR) ,” will study out-of-hospital naloxone administration through a collaboration with EMS agencies in San Francisco, CA; Detroit, MI; Portland, OR; and Pittsburgh, PA.
  • ACMT’s Board President, Anthony Pizon, MD, FACMT states, “The RENDOR project aims for a better understanding of how naloxone is being used now that it has been made more accessible and widely available.
  • ACMT members work in clinical, academic, governmental, and public health settings, and provide poison control center leadership.
  • Led by medical toxicology physicians and registry experts, our projects involve case registry design and maintenance.

CDC Launches Fentanyl Dashboard Utilizing Data from the Toxicology Investigators Consortium (ToxIC) to Monitor Nonfatal Overdose Trends

Retrieved on: 
Friday, June 9, 2023
Maintenance, Xylazine, Methamphetamine, Icahn School of Medicine at Mount Sinai, Principal investigator, Drug Safety, Fentanyl, Toxicology, Research, Risk, Mount Sinai, Heroin, CDC, Abuse, Hospital, Cocaine, Patient, Physician, NIDA, Drug, Toxicity, American College of Medical Toxicology, American College, Medical device, Pharmaceutical industry, Education

In response to this growing crisis, the CDC has collaborated with ToxIC, a multicenter research network led by physicians specializing in medical toxicology, to develop a comprehensive toxico-surveillance dashboard that captures real-time data on nonfatal overdoses involving fentanyl.

Key Points: 
  • In response to this growing crisis, the CDC has collaborated with ToxIC, a multicenter research network led by physicians specializing in medical toxicology, to develop a comprehensive toxico-surveillance dashboard that captures real-time data on nonfatal overdoses involving fentanyl.
  • The new dashboard, “Fentalog Study: A Subset of Nonfatal Suspected Opioid-Involved Overdoses with Toxicology Testing” went live in May of 2023.
  • It examines the clinical effects of fentanyl analogs among suspected opioid overdoses and utilizes ToxIC's extensive network of healthcare facilities to aggregate and analyze nonfatal overdose data.
  • The American College of Medical Toxicology (ACMT) is a professional, nonprofit association of physicians with recognized expertise and board certification in medical toxicology.

Shatterproof Applauds the Passage of the MATE Act to Expand Addiction Education

Retrieved on: 
Friday, December 23, 2022
Public Policy, Government, White House, Federal Government, Public Policy, General Health, Health, Mental Health, Healthcare Reform, Congressional News, Views, Well, Education, Doctor of Nursing Practice, Addiction, Mental health, Legislation, School, Pain, SUD, Substance-related disorder, American College, Health, Voices, Omnibus Appropriations Act, 2009, SMART Recovery, House, Drug Safety, Organization, Buprenorphine, National Council, Drug Enforcement Administration, Federation, National Safety Council, American Society of Addiction Medicine, Drug, Opioid use disorder, Research, MAT, Patient, Representative, Curriculum, Society, Oxford, OUD, Maintenance, Student, American College of Medical Toxicology, MATE, Congress, Suds, Louisiana House of Representatives, University, Addiction medicine, DEA, Speech disorder, Pharmaceutical industry, Medicine, The 39 Clues

Shatterproof applauds the passage of the Medication Access and Training Expansion (MATE) Act (H.R.

Key Points: 
  • Shatterproof applauds the passage of the Medication Access and Training Expansion (MATE) Act (H.R.
  • Passage of the MAT Act along with the MATE Act will enable better access to life-saving treatment.
  • The MATE Act mainstreams addiction medical education on SUDs across the nation’s medical educational programs.
  • Shatterproof worked closely with the American Society of Addiction Medicine on the passing of the MATE Act.

Symposium to Address Suicidality, Bridging Toxicology and Mental Health

Retrieved on: 
Friday, December 9, 2022
GiFT, Intersection, Symposium, Mental health, Physician, MPH, Psychology, American College of Medical Toxicology, Emergency medicine, Toxicology, San Diego Marriott Marquis & Marina, Death, American College, Poisoning, Forensic toxicology, Addiction medicine, Central nervous system, Ethics, Military medicine, Drug Safety, Symptoms of COVID-19, Risk, Public health, Patient, Medicine, Residential care, Pharmaceutical industry, Suicide, Psychiatry, MD

Phoenix, AZ, Dec. 09, 2022 (GLOBE NEWSWIRE) -- After a 2-year hiatus from in-person activities, The American College of Medical Toxicology (ACMT ) is pleased to present a full-day symposium exploring the intersection of medical toxicology and mental health.

Key Points: 
  • Phoenix, AZ, Dec. 09, 2022 (GLOBE NEWSWIRE) -- After a 2-year hiatus from in-person activities, The American College of Medical Toxicology (ACMT ) is pleased to present a full-day symposium exploring the intersection of medical toxicology and mental health.
  • The event, titled “ Self-Harm, Suicidality, and the Poisoned Patient: The Intersection of Toxicology and Mental Health ,” will take place on Thursday, March 30, 2023 at the San Diego Marriott La Jolla.
  • This program brings together distinguished experts in Medical Toxicology, Psychiatry, Emergency Medicine, Medical Ethics, Military Medicine, Addiction Medicine, Public Health and related fields.
  • The American College of Medical Toxicology (ACMT) is a professional, nonprofit association of physicians with recognized expertise and board certification in medical toxicology.

Kenneth D. Katz, MD, FACMT, FAAEM, FACEP is recognized by Continental Who's Who

Retrieved on: 
Friday, April 22, 2022
Well, American Board of Internal Medicine, American College of Medical Toxicology, American Board of Commissioners for Foreign Missions, GiFT, American Academy of Emergency Medicine, Internal, Medicine, American Board of Emergency Medicine, ABEM, Stony Brook University, Association, Drug Safety, MD, Yale University, Medical degree, Internal medicine, Continental, Patient, Loving Memory, Speech disorder, Student, Attending physician, ABIM, Drug, Journal, American College, Parent, Critical care, 2021 Essex County Council election, Medical specialty, Emergency medicine, American Academy, Physician, Multimedia, Fellow of the American College of Emergency Physicians, FACEP, American Board of Medical Specialties, Clinical Toxicology, Biology

Kenneth D. Katz, MD, FACMT, FAAEM, FACEP, is a Medical Toxicology Specialist with experience in treating medical emergencies, overdoses, and substance use disorders.

Key Points: 
  • Kenneth D. Katz, MD, FACMT, FAAEM, FACEP, is a Medical Toxicology Specialist with experience in treating medical emergencies, overdoses, and substance use disorders.
  • With more than 25 years of medical experience, Dr. Katz practices at Lehigh Valley Physician Group, one of the largest medical groups in the United States.
  • With over 160 clinics nationwide, the group includes more than 1,000 physicians and 600 advanced practice specialists.
  • In his spare time, Dr. Katz enjoys spending time with his wife of 17 years, Mrs. Kristina Katz, and their son, Ethan.

X Waiver Mini-Course Expands Emergency Clinician Recognition and Treatment of Opioid Withdrawal, Study Finds

Retrieved on: 
Wednesday, April 13, 2022
Confusion, American College of Medical Toxicology, Pharmacology, IBC, Families Empowered and Supporting Treatment of Eating Disorders (F.E.A.S.T.), MTF, Perelman School of Medicine at the University of Pennsylvania, Research, Drug Safety, Opioid use disorder, Center, OUD, JMT, GLOBE, Education, Policy, Patient, Addiction medicine, Emergency medicine, Physiology, Principal, Independence Blue Cross Foundation, Journal of Medical Toxicology, Journal, American College, University, EM, Independence Blue Cross, Physician, Certification, STOP, Association, Knowledge, Medicine, Pharmaceutical industry, Buprenorphine

Buprenorphine is one of three evidence-based treatments for opioid use disorder and can be initiated by any clinician for the treatment of opioid withdrawal.

Key Points: 
  • Buprenorphine is one of three evidence-based treatments for opioid use disorder and can be initiated by any clinician for the treatment of opioid withdrawal.
  • Despite the evidence in support of the use of buprenorphine in the treatment of Opioid Use Disorder (OUD), emergency department (ED)-initiated buprenorphine is still uncommon.
  • Many emergency medicine (EM) clinicians lack training on how to manage acute opioid withdrawal or initiate treatment with buprenorphine.
  • This change potentially allows every emergency clinician to be capable of initiating treatment for patients experiencing withdrawal.

American College of Medical Toxicology Presents 2022 Virtual Annual Scientific Meeting & Symposium

Retrieved on: 
Tuesday, January 25, 2022
FACEP, Emergency medicine, Safety, Internal medicine, Division, University of Massachusetts Medical School, Physician, Vaccination, Illinois College, Guy's and St Thomas' NHS Foundation Trust, Department, COVID-19, NHS foundation trust, Research, University of Texas Southwestern Medical Center, Thrombosis, New Jersey Medical School, University, Substance abuse, University and college admission, Guy Dain, Doctor of Philosophy, Addiction medicine, King's College London, Bachelor of Science, Dean (education), National Institute, American College of Medical Toxicology, American College, OBE, Drug Safety, National Institute on Drug Abuse, Association, Pharmaceutical industry, Hospital, Medicine, MD

ACMT's 2022 Annual Scientific Meeting will feature 40 presentations of original research: 8 platforms, 7 lightning orals, 25 moderated posters, in addition to 130+ posters in our interactive e-Gallery.

Key Points: 
  • ACMT's 2022 Annual Scientific Meeting will feature 40 presentations of original research: 8 platforms, 7 lightning orals, 25 moderated posters, in addition to 130+ posters in our interactive e-Gallery.
  • This 3-day event provides an opportunity for specialists in the field of medical toxicology, addiction medicine, emergency medicine, and more to connect, network, and learn from the cutting-edge research of their peers.
  • Because this event is virtual, registrants may enjoy the flexibility of participating live or accessing presentations later on-demand at their convenience.
  • About ACMT The American College of Medical Toxicology (ACMT) is a professional, nonprofit association of physicians with recognized expertise and board certification in medical toxicology.

Illicit Benzodiazepine Overdose Trends Detected by Toxicology Investigators Consortium (ToxIC)

Retrieved on: 
Thursday, September 2, 2021
Anxiety, DO, Disease, Morbidity and Mortality Weekly Report, Icahn School of Medicine at Mount Sinai, South Carolina Opioid Overdose Prevention Bill, District, Naloxone, Death, MMWR, American College of Medical Toxicology, Physician, Association, Seizure, American College, Toxicity, Benzodiazepine, Drug Safety, GLOBE, Drug, Pharmaceutical industry

This publication presents a detailed evaluation of 21 suspected opioid overdoses in which illicit benzodiazepines were detected.

Key Points: 
  • This publication presents a detailed evaluation of 21 suspected opioid overdoses in which illicit benzodiazepines were detected.
  • Concurrent exposure to both illicit benzodiazepines and opioids may increase overdose risk and/or make treatment for opioid overdose increasingly difficult.
  • The 5-year study, entitled"Predicting Medical Consequences of Novel Fentanyl Analog Overdose Using theToxicology Investigators Consortium (ToxIC), includes 9 geographically diverse ToxIC sites around the country.
  • The American College of Medical Toxicology (ACMT) is a professional, nonprofit association of physicians with recognized expertise and board certification in medical toxicology.